Chemerin treatment more significantly inhibited cell invasion than cell viability in breast cancer cells in the presence or absence of TGF-β and IGF-1, which are growth factors that stimulate cancer cell invasion and are released from the bone matrix by osteolysis. The gene discussed is IGF1; the disease is breast carcinoma.